Hamps Bio IPO

Hamps Bio Limited

₹1,02,000 /2000 sharesMinimum Investment

Hamps Bio IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
13 Dec ‘24 - 17 Dec ‘24₹1,02,0002,000₹51 - ₹51
Issue SizeIPO Doc
6.22Cr
RHP PDF

About Hamps Bio

Hamps Bio markets and distributes pharmaceutical products in various forms, including tablets, syrups, capsules, injectables, oils, gels, and powders. These products are used both as medicines and nutritional supplements. Additionally, the company produces freeze-dried and frozen products, such as fruits, vegetables, herbs, and flowers, through its FMCG (or FDFP) division.;
Founded in
2007
Managing director
Mr. Herrik Shah
Parent organisation
Hamps Bio Limited

Strengths & Financials of Hamps Bio

Strengths
Risks
As of October 31, 2024, Hamps Bio distributes its products through a network of over 50 distributors and various e-commerce platforms, including Amazon (US, Canada, Europe), Flipkart, and Jio Mart.
The company sells its pharmaceutical products in 8 states and Union Territories of India, while its freeze-dried and frozen products are marketed in 22 states and Union Territories and 6 countries. In total, Hamps Bio offers more than 180 different products across both segments.
Hamps Bio claims to have established 32 brands, offering over 100 products in the pharmaceutical segment, primarily targeting the domestic market.
The company is ISO 9001:2015 certified for quality management systems and ISO 22000:2018 certified for food safety management systems. The company also holds certifications from the US Food and Drug Administration (FDA) and the Food Safety and Standards Authority of India (FSSAI).
The company has seen a consistent increase in revenue from operations and profit after tax (PAT). Revenue from operations increased from Rs 5.34 crore in FY22 to Rs 5.58 crore in FY23 to Rs 6.47 crore in FY24. Though small, PAT too increased from Rs 0.12 crore in FY22 to Rs 0.36 crore in FY23 to Rs 0.50 crore in FY24.

Hamps Bio Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Hamps Bio IPO

Apply asPrice bandApply upto
Regular51 - 51₹2 Lakh
High Networth Individual51 - 51₹2 - 5 Lakh
For Hamps Bio IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW